|
Table of Contents
PART I STATUS OF AGRICULTUTAL BIOTECHNOLOGY AND THE CORRESPONDING BIOSAFETY EVALUATIONS
1.Pilot Experiment, Environmental Release and Commercialisation of Genetically Modified Organisms Undertaken by Chinese Universities
2.Advances in Agrobiotechnology and the Safety Evaluation of Transgenic Organisms in China
3.Current Developments of Agricultural Biotechnology in Europe
4.Status of Agricultural Biotechnology in the United States
PART Ⅱ REGULATORY FRAMEWWORKS
5. The Chinese National Biosafety Framework Project
6. An Introduction to the SSTC Safety regulation of Genetic Engineering in china
7. Safety Assessments Frameworks for Transgenic Crops in Japan
8. Biosafety Legislation and Legal Systems in China
9. The Co-ordinated Framework for Regulation of biotechnology in the United States
10.The Structure and Content of the Proposed National Biosafety Regulation in china
PART Ⅲ IMPLEMENTING BIOSAFETY REGULATORY FRAMEWORKS
11.Safety Administration and Agricultural Biological Genetic Engineering in china
12.Risk Assessment Practice in The Netherlands
13.Safety Administration Of Agricultural Biological Genetic Engineering In China
14.The OECD Work Programme on the Harmonisation of regulatory Oversight in Biotechnology
15.USDA-APHIS assessment of Transgenic Plants
PART Ⅳ ASSESSMENT AND MONITORING OF THE IMPACTS OF GENETICALLY MODIFIED ORGANISMS
16.Impact and Consequences of the Release and Commercialisation of GM Crops
Biosafety: Issues for Concern
17.Impact at the genetic level
18.Safety Evaluation of foods Derived by Modern Biotechnology
19.An Introduction to Transgenic Animal: Research and Biosafety in China
20.Transgenic Virus-Tolerant Plants - What Do We Need To Know?
21.The Development and Regulation of Tree Biotechnology in china
22.Practical Views On Biotechnology Product Monitoring
23.Safety Assessment of Transgenic Bt cotton
24.Socio-economic Impacts and Safety Issues of Modern Biotechnology
PART Ⅴ BIOSAFETY CAPACITY BUILDING AND HARMONISING RISK ASSESSMENT PROCEDURES
25.Criteria for Successful Biosafety Capacity Building
26.National Capacity Building for Risk Assessment and Risk Management of Transgenic Organisms
27.Harmonization and Common Criteria for Risk Assessments
PATR Ⅵ SUMMARY OF WORKING GROUP SESSIONS
Working Group IBiosafety Regulatory Mechanisms, Sharing Experiences and Capacity building
Working Group ⅡRisk Assessment, Risk Management and Monitoring of Genetically Modified Organisms
AppendixⅠ: List of Participants
AppendixⅠ: List of Internet Address on Biosafet
|
Contact us 
